BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34949659)

  • 1. SIRT5 Directly Inhibits the PI3K/AKT Pathway in Prostate Cancer Cell Lines.
    Choi SY; Jeon JM; Na AY; Kwon OK; Bang IH; Ha YS; Bae EJ; Park BH; Lee EH; Kwon TG; Lee JN; Lee S
    Cancer Genomics Proteomics; 2022; 19(1):50-59. PubMed ID: 34949659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDHA Desuccinylase Sirtuin 5 as A Novel Cancer Metastatic Stimulator in Aggressive Prostate Cancer.
    Kwon OK; Bang IH; Choi SY; Jeon JM; Na AY; Gao Y; Cho SS; Ki SH; Choe Y; Lee JN; Ha YS; Bae EJ; Kwon TG; Park BH; Lee S
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):177-189. PubMed ID: 35278714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.
    Ma T; Chen H; Wang P; Yang N; Bao J
    Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162
    [No Abstract]   [Full Text] [Related]  

  • 4. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
    Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quercetin inhibits DNA damage responses to induce apoptosis via SIRT5/PI3K/AKT pathway in non-small cell lung cancer.
    Zhou B; Yang Y; Pang X; Shi J; Jiang T; Zheng X
    Biomed Pharmacother; 2023 Sep; 165():115071. PubMed ID: 37390710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway.
    Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q
    Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
    Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl-CoA acetyltransferase 1.
    Guan J; Jiang X; Gai J; Sun X; Zhao J; Li J; Li Y; Cheng M; Du T; Fu L; Li Q
    J Cell Mol Med; 2020 Dec; 24(23):14039-14049. PubMed ID: 33103371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of PI3K/Akt Signaling Pathway on the Process of Prostate Cancer Metastasis to Bone.
    Zhu W; Hu X; Xu J; Cheng Y; Shao Y; Peng Y
    Cell Biochem Biophys; 2015 May; 72(1):171-7. PubMed ID: 27040945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathway.
    Wei A; Fan B; Zhao Y; Zhang H; Wang L; Yu X; Yuan Q; Yang D; Wang S
    Oncotarget; 2016 Oct; 7(40):65374-65388. PubMed ID: 27588482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K/Akt pathway.
    Hou Y; Li H; Huo W
    Prostate; 2020 Jul; 80(10):753-763. PubMed ID: 32421868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zingerone suppresses cell proliferation via inducing cellular apoptosis and inhibition of the PI3K/AKT/mTOR signaling pathway in human prostate cancer PC-3 cells.
    Qian S; Fang H; Zheng L; Liu M
    J Biochem Mol Toxicol; 2021 Jan; 35(1):e22611. PubMed ID: 32905641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
    Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
    Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
    Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
    Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
    Graham TR; Odero-Marah VA; Chung LW; Agrawal KC; Davis R; Abdel-Mageed AB
    Prostate; 2009 Feb; 69(2):168-80. PubMed ID: 18942118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.